OVA Conjugated Major Basic Protein (MBP)

PRG2; BMPG; Proteoglycan 2; Bone Marrow,Natural Killer Cell Activator; Eosinophil Granule Major Basic Protein; Proteoglycan 2,Bone Marrow; Pregnancy-associated major basic

FORMULA

USAGE

Reconstitute in ddH2O to a concentration of 0.1-1.0 mg/mL. Do not vortex.

STORAGE

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

STABILITY

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Evid Based Complement Alternat Med Inhibitory Action of Quercetin on Eosinophil Activation In Vitro PubMed: PMC3690238
Clinical and Molecular Allergy Markers of atopic dermatitis, allergic rhinitis and bronchial asthma in pediatric patients: correlation with filaggrin, eosinophil major basic protein and …
Catalog No. Related products for research use of Organism species Applications (RESEARCH USE ONLY!)
CPB650Mi21 OVA Conjugated Major Basic Protein (MBP) Immunogen; SDS-PAGE; WB.